Johnson & Johnson, already a big player in neuroscience drugs, is adding to its portfolio and pipeline with a deal to acquire Intra-Cellular Therapies, a company whose main asset has the potential to ...

Just as the word 'bat' becomes 'cat' by changing a letter, thus describing two distinct animals with very different abilities ...